Clinical Trial Update: Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen [Phase 4]

View source ↗

Summary

Phase 4 trial updating efficacy and safety of celecoxib versus placebo in knee osteoarthritis patients unresponsive to naproxen and ibuprofen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Osteoarthritis, Knee | Phase 4 | Status: COMPLETED